Status
Conditions
Treatments
About
Adapted physical activity session with a formed professional is proposed in standard care since 2022 in the immuno-hematological service to all children with newly diagnosed cancer or relapse.
The aim of this study is to keep the children in the APA programm during all the treatment lenght.
This study aims to evaluate by questionnaires the motivation keys and restraint from children and parents before the APA program starts (at diagnosis or relapse if not previously participating to an APA programm) and after 4 to 6 months of APA programm.
The final expected fallout is to enhance children adhesion to long term APA program by implementing tools in current practice to overcome restraints from young patients and their parents
Full description
The literature and the French Cancer Plan confirm the benefits of physical activity for cancer patients, and underline the importance of developing appropriate physical activity support for children and adolescents, given their specific needs and the societal and public health challenge represented by these budding patients.
Despite the abundance of studies relating to physical activity in oncology, few data are available, particularly in the pediatric and adolescent/young adult population :
This is a prospective, exploratory, monocentric study to explore these points.
As part of routine management in the immunohaemato-oncology [IHO] department of the Grenoble Alpes University Hospital, a personalized physical activity [PA] program is systematically proposed by a PA professional, with a program adapted to the child, his or her motivations and limitations.
As part of the protocol, a questionnaire-based assessment of motivations and obstacles, as well as quality of life, will be carried out at the start of the PA program and again after 4 to 6 months. Criteria for adherence to the APA program will also be collected.
EXPECTED OUTPUTS
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Diagnosis of acute or chronic hematological malignancy OR Central nervous system tumors OR Other solid tumors
Exclusion criteria
Loading...
Central trial contact
Isabelle Schiff, PHD; Laura Chambon
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal